Madelyn D. Purcell
Pfizer Inc
Assets Managed
$238.776M
Holdings
18
Last Quarter
2026 - Q1
Filed Date
4d ago
Growth Rate
0.98%(2Q avg: -22.48%)
Sustained Growth
1 quarters
Portfolio positions
This chart displays the top 10 holdings in Pfizer Inc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 18 positions.
Assets under management
The assets under management (AUM) of Pfizer Inc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 238.776M in assets, with a quarterly growth rate of 0.98% and a 2-quarter average growth rate of -22.48%. The portfolio is managed by Madelyn D. Purcell, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
ORIC Oric Pharmaceuticals Inc
| 24.15% | $57.652M 4.78M shares@ $12.06 avg price | Decreased -11.08% |
ALLO Allogene Therapeutics Inc
| 20.86% | $49.792M 22.032M shares@ $2.26 avg price | |
ARVN Arvinas Inc
| 14.63% | $34.924M 3.458M shares@ $10.11 avg price | |
CELC Celcuity Inc
| 13.13% | $31.345M 295,652 shares@ $106.02 avg price | Decreased -15.38% |
ZURA Zura Bio Ltd
| 7.06% | $16.835M 2.839M shares@ $5.93 avg price | Decreased -4.41% |
WVE Wave Life Sciences Ltd
| 5% | $11.934M 1.875M shares@ $6.37 avg price | |
PYXS Pyxis Oncology Inc
| 3.86% | $9.213M 7.033M shares@ $1.32 avg price | |
CRBU Caribou Biosciences Inc
| 3.5% | $8.349M 4.69M shares@ $1.78 avg price | |
SPRO Spero Therapeutics Inc
| 2.31% | $5.504M 2.362M shares@ $2.34 avg price | |
BHVN Biohaven Ltd
| 1.78% | $4.232M 505,645 shares@ $8.38 avg price |
1-10 of 18